Display Settings:

Format

Send to:

Choose Destination
    Crit Rev Oncol Hematol. 2002 May;42(2):163-71.

    What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?

    Source

    Dana Farber/Partners Cancer Care, Harvard Medical School, Boston, MA, USA. rbenjamin@partners.org

    Abstract

    Platelet transfusion therapy is an integral part of modern oncological practice and is used to treat hemorrhage associated with thrombocytopenia. More commonly, platelets are transfused to prevent hemorrhage in thrombocytopenic patients. Conventional wisdom has suggested a threshold for prophylactic transfusion of <20x10(9)/l. Many studies now support the safety of more conservative transfusion regimes that reduce patient exposure to donors and conserve precious resources, without an increase in risk of hemorrhage. This review presents the data to support the use of a prophylactic transfusion threshold of <10x10(9)/l in patients without risk factors for hemorrhage and who have ready access to emergent medical care.

    PMID:
    12007974
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk